Pharmacogenomics‐Based Point‐of‐Care Clinical Decision Support Significantly Alters Drug Prescribing

Ph O'Donnell, Nisha R. Wadhwa, Keith Danahey, Ba Borden, Siow Ming Lee, Julianne Hall, Catherine Klammer, Sheena Hussain, Mark Siegler, Mj Sorrentino, Andrew M. Davis, Ya Sacro, Rachita Nanda, Ts Polonsky, Jl Koyner, Dl Burnet, K Lipstreuer, Dt Rubin, Cathleen Mulcahy, Me Strek, William R. Harper, As Cifu, Blasé N. Polite, Linda Patrick‐Miller, K. L. B. Yeo, Eky Leung, Sl Volchenboum, Russ B. Altman, Oi Olopade, Wm Stadler, Do Meltzer, Mj RatainClinical 2017 · DOI

Abstract

Changes in behavior are necessary to apply genomic discoveries to practice. We prospectively studied medication changes made by providers representing eight different medicine specialty clinics whose patients had submitted to preemptive pharmacogenomic genotyping. An institutional clinical decision support (CDS) system provided pharmacogenomic results using traffic light alerts: green = genomically favorable, yellow = genomic caution, red = high risk. The influence of pharmacogenomic alerts on prescribing behaviors was the primary endpoint. In all, 2,279 outpatient encounters were analyzed. Independent of other potential prescribing mediators, medications with high pharmacogenomic risk were changed significantly more often than prescription drugs lacking pharmacogenomic information (odds ratio (OR) = 26.2 (9.0-75.3), P < 0.0001). Medications with cautionary pharmacogenomic information were also changed more frequently (OR = 2.4 (1.7-3.5), P < 0.0001). No pharmacogenomically high-risk medications were prescribed during the entire study when physicians consulted the CDS tool. Pharmacogenomic information improved prescribing in patterns aimed at reducing patient risk, demonstrating that enhanced prescription decision-making is achievable through clinical integration of genomic medicine.
BibTeX
@inproceedings{odonnell2017pharmacogenomicsbased,
  author = {PH O'Donnell and Nisha R. Wadhwa and Keith Danahey and BA Borden and Siow Ming Lee and Julianne Hall and Catherine Klammer and Sheena Hussain and Mark Siegler and MJ Sorrentino and Andrew M. Davis and YA Sacro and Rachita Nanda and TS Polonsky and JL Koyner and DL Burnet and K Lipstreuer and DT Rubin and Cathleen Mulcahy and ME Strek and William R. Harper and AS Cifu and Blasé N. Polite and Linda Patrick‐Miller and K. L. B. Yeo and EKY Leung and SL Volchenboum and Russ B. Altman and OI Olopade and WM Stadler and DO Meltzer and MJ Ratain},
  title = {{Pharmacogenomics‐Based Point‐of‐Care Clinical Decision Support Significantly Alters Drug Prescribing}},
  booktitle = {Clinical},
  year = {2017},
  doi = {10.1002/cpt.709},
}

Loading related content...

Figure